2Clarkson M R,Giblin L,O'Connell F P,et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy[ J]. Nephrol Dial Transplant ,2004,19 ( 11 ) :2778-2783.
3Mori Y, Kishimoto N, Yamahara H, et al. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis[J]. Clin Exp Nephro ,2005,9 ( 1 ) :79-84.
5Neilson E G. Pathogenesis and therapy of interstitial nephritis[ J]. Kidney lnt, 1989,35 (5) :1257-1270.
6Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glyco- proteins:biology and clinical relevance [ J ]. Arn J Kidney Dis, 2003,42(4) :658-676.
7Neilson E G. Mechanisms of disease:fibroblasts-a new look at an old problem [ J ]. Nat Clin Pract Nephrol,2006,2 ( 2 ) : 101 -108.
8Kuhlmann A, Haas C S, Gross M L, et al. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat [ J ]. Ant J Physiol Renal Physiol, 2004, 286(3) : F526-F533.
9Perazella M A, Markowitz G S. Drug-induced acute interstitial nephritis [J]. Nat Rev Nephro1,2010,6 ( 8 ) :461 - 470.
10Koselj M, Kveder R, Bren A F,et al. Acute renal failure in patiens with drug-induced acute interstitial nephritis [ J ]. Ren fail, 1993,15 ( 1 ) :69-72.
